Company intelligence / Profile preview

Canavation Product Group

Tampa, Florida, United States

Ownership: Private
Employees: ~2
Development stage: Other

Overview

Canavation Product Group is a consumer goods company focused on developing and marketing cannabinoid-infused products. They leverage proprietary technology for converting hemp-derived CBD into Δ8THC and Δ9THC, and hold access to Teewinot's CannSynthesis® biotechnology platform. The company aims to differentiate its offerings, expand product lines, and license its patented processes.

Industry: Non-Drug Biotech

Partnerships

Teewinot Life Sciences (strategic supply agreement)

Beyond the preview

Go deeper on Canavation Product Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Canavation Product Group.

Explore the full profile